Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGC
- Status
- UNKNOWN
- Phase
- PHASE2
S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases
- Status
- UNKNOWN
- Phase
- PHASE4
Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
(PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers
- Status
- COMPLETED
- Phase
- PHASE3
Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2